The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $189.27

Today's change+2.12 +1.13%
Updated October 19 4:02 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $189.27

Today's change+2.12 +1.13%
Updated October 19 4:02 PM EDT. Delayed by at least 15 minutes.

Allergan plc up (U.S.)$2.12

Allergan plc closed up Thursday by (U.S.)$2.12 or 1.13% to (U.S.)$189.27. Over the last five days, shares have lost 7.26% and sit 3.54% above their 52-week low. This security has underperformed the S&P 500 by 36.80% during the last year.

Key company metrics

  • Open(U.S.) $185.00
  • Previous close(U.S.) $187.15
  • High(U.S.) $190.69
  • Low(U.S.) $182.80
  • Bid / Ask-- / --
  • YTD % change-9.88%
  • Volume7,624,500
  • Average volume (10-day)4,619,872
  • Average volume (1-month)3,631,504
  • Average volume (3-month)2,511,864
  • 52-week range(U.S.) $182.80 to (U.S.) $256.80
  • Beta1.15
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward11.68×
  • Forward PEG1.03×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.48%
  • Trailing EPS(U.S.) -$11.66
Updated October 19 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue4,0073,5733,8643,622
Total other revenue--------
Total revenue4,0073,5733,8643,622
Gross profit3,4573,1233,3853,160
Total cost of revenue550450480462
Total operating expense5,0714,4794,7643,889
Selling / general / administrative1,3951,1851,2771,157
Research & development1,1931,1001,340665
Depreciation / amortization1,7581,7361,6391,609
Interest expense (income), net operating--------
Unusual expense (income)176729-5
Other operating expenses, total--------
Operating income-1,064-906-900-266
Interest income (expense), net non-operating-277-290-293-324
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,297-3,093-1,111-539
Income after tax-716-2,561-40-380
Income tax, total-581-532-1,071-159
Net income-726-2,565-115,220
Total adjustments to net income-70-70-70-70
Net income before extra. items-718-2,562-42-382
Minority interest-2-1-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-787-2,632-112-452
Inc. avail. to common incl. extra. items-796-2,635-7015,150
Diluted net income-796-2,635-7015,150
Dilution adjustment--------
Diluted weighted average shares335335356393
Diluted EPS excluding extraordinary itemsvalue per share-2.35-7.85-0.31-1.15
Dividends per sharevalue per share0.700.70--0.00
Diluted normalized EPSvalue per share-2.01-7.84-0.26-1.16